Active substanceSulfadimethoxinSulfadimethoxin
Similar drugsTo uncover
  • Sulfadimezine
    pills inwards 
    IRBITSK HFZ, OJSC     Russia
  • Sulfadimethoxin
    pills inwards 
    BIOCHEMIST, OJSC     Russia
  • Sulfadimethoxin
    pills inwards 
  • Sulfadimethoxin
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Sulfadimethoxin
    pills inwards 
    IRBITSK HFZ, OJSC     Russia
  • Dosage form: & nbspPills.
    Composition:
    Composition per one tablet:
    active substance: sulfadimethoxin -500 mg;
    auxiliary substances: microcrystalline cellulose - 42.0 mg, crospovidone - 26.5 mg, povidone (medium molecular weight polyvinylpyrrolidone, povidone K-25) - 25.5 mg. calcium stearate - 6.0 mg.
    Description:Round flat cylindrical tablets white or white with a creamy shade of color with a facet and a risk.
    Pharmacotherapeutic group:Antimicrobial agent, sulfonamide.
    ATX: & nbsp

    J.01.E.D.   Sulfonilamides of long duration

    Pharmacodynamics:
    Antimicrobial bacteriostatic agent. The mechanism of action caused by a competitive antagonism with para-aminobenzoic acid, inhibition digidropteroatsintetazy, tetrahydrofolic acid synthesis disorder necessary for the synthesis of purines and pyrimidines. It is active against gram-positive and gram-negative microorganisms: Staphylococcus spp., Streptococcus spp., Incl.Streptococcus pneumoniae, Friedlander sticks, Escherichia coli, Shigella spp., Chlamydia trachomatis.
    Sulfadimethoxin does not act on strains of bacteria resistant to sulfonamides.
    Pharmacokinetics:
    When ingested, absorbed relatively slowly, found in the blood after 30 minutes. With a single dose (in a dose of 1-2 g), the time to reach the maximum concentration in the blood (Tcmax) - 8-12 hours.
    Therapeutic concentration in adults is achieved by taking 1 -2 g in 1 day and 0.5-1 g in the following days. Communication with blood proteins - 90-99%.
    The drug accumulates in the blood, primarily due to the high degree of binding to blood proteins (90-99%). Well distributed to organs and systems. But unlike other representatives of long-acting sulfanilamides, poorly penetrates the hemato-encephalic barrier (BBB) ​​and its concentration in the cerebrospinal fluid is low. However, with inflammation of the meningeal membranes, the permeability of the BBB sharply increases. It penetrates well into the pleural fluid (60-90% of the concentration in the blood), in the biliary system, where its concentration is 1.5-4 times higher than in the blood.
    The preferential metabolism is carried out along the path of microsomal glucuronation, which is associated with cytochrome P450 and NADPH-dependent.
    Strong connection with blood plasma proteins and high reabsorption in the tubules of the kidneys (93-97.5%), promotes the slow removal of the drug from the body. The blood contains 5-15% of acetylated metabolites, in urine - 10-25% of acetyl derivatives and 75-90% of glucuronide sulfadimethoxin; the latter is readily soluble and does not provoke the development of crystalluria. The acetyl derivative is not reabsorbed and is completely excreted by the kidneys. After 24 hours, 20-40% of the dose taken out, after 48 hours - up to 56%, after 96 hours - up to 83.3%.
    Indications:Diseases caused by sensitive microflora: tonsillitis, otitis media, sinusitis; bronchitis, pneumonia; dysentery; pyoderma; erysipelas; trachoma; wound infections; gonorrhea; diseases of the urinary and biliary tract; malaria (as part of complex therapy).
    Contraindications:
    Hypersensitivity to sulfadimethoxin or other components of the drug; oppression of bone marrow hemopoiesis; renal / hepatic insufficiency, chronic heart failure, congenital deficiency of glucose-6-phosphate dehydrogenase; porphyria; azotemia;
    pregnancy and the period of breastfeeding, children under 12 years (for this dosage form and dosage).
    Pregnancy and lactation:
    The use of the drug during pregnancy and during breastfeeding is contraindicated. If you need to use the drug during lactation, you should decide whether to stop breastfeeding.
    Dosing and Administration:
    Inside, 1 time per day. Adults, in the first day - 1-2 grams, then - 0.5-1 g / day.
    For children from 12 to 18 lay: the initial and maintenance doses are equal, respectively, 1 g and 0.5 g.
    After normalizing the temperature, the drug in maintenance doses is used for 2-3 more days. The course of treatment, depending on the severity of the disease,
    is 7-14 days.
    Side effects:Allergic reactions; headache, dyspepsia, leukopenia, agranulocytosis, cholestatic hepatitis.
    Interaction:
    The effect of sulfadimethoxin is enhanced when combined with diaminopyrimidine derivatives (trimethoprim, tetroxoprim, pyrimethamine).
    Reduces the effectiveness of bactericidal antibiotics, acting only on fissile microorganisms (including penicillins, cephalosporins). Phenytoin increases the risk of developing toxic reactions.
    Methotrexate and other folic acid antagonists increase the risk of developing a deficiency of folic acid.
    Procaine, benzocaine and tetracaine reduce antibacterial activity. PASK and barbiturates intensify the antimicrobial effect. Salicylates increase the activity and toxicity of sulfadimethoxin. Metoksalen promotes the development of photosensitization. Non-hormonal anti-inflammatory drugs, thioacetazone, chloramphenicol increase the toxic effect on the blood (leukopenia, agranulocytosis).
    Strengthens the effect of anticoagulants of indirect action, phenytoin, sulfonamides with hypoglycemic action;
    The derivatives of pyrazolone, indomethacin and salicylates increase the free fraction of the drug in the blood.
    Reduces the effectiveness of oral contraceptives. Enhances the metabolism of cyclosporine.
    Special instructions:During therapy, a generous drink is recommended, regular monitoring of blood and urine indicators.
    Effect on the ability to drive transp. cf. and fur:During the treatment period, care should be taken when driving vehicles and engaging in other potentially hazardous activities requiring increased attention and speed of psychomotor reactions.
    Form release / dosage:
    Tablets 500 mg.

    Packaging:
    For 10 tablets in a planar cell package.1, 2 or 3 contour squares, together with instructions for use in a pack of cardboard. It is allowed to place contoured cells in a group package with an equal number of instructions.
    Storage conditions:Store at a temperature not exceeding 25 ° C. Keep out of the reach of children.
    Shelf life:5 years. Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:LS-002420
    Date of registration:18.08.2010
    The owner of the registration certificate:PHARMSTANDART-FORESTRY, OJSC PHARMSTANDART-FORESTRY, OJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp27.08.2015
    Illustrated instructions
      Instructions
      Up